Episode 504: ASCO 2026 - ADC Drug Development in Urothelial Cancer
From The Uromigos · · 40 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
This episode with Gopa Iyer from MSKCC explores the latest advances in antibody drug conjugates (ADCs) in urothelial cancer, including data from EV302, novel ADCs targeting Nectin-4, and sequencing strategies. Experts discuss efficacy, safety, biomarkers, and future directions in bladder cancer treatment.